Literature DB >> 15698

The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen.

A G Blakeley, R J Summers.   

Abstract

1. The competitive alpha- and beta-adrenoceptor blocking agent labetalol, in concentrations up to 10(-4) M, produced dose-dependent increases in transmitter overflow from the isolated blood perfused spleen of the cat following nerve stimulation at 10 and 30 Hz. 2. At concentrations above 10(-4) M labetol produced a pronounced decrease in transmitter overflow. 3. Labetalol (1.5 X 10(-4) M) increased the recovery of 3H label in the venous blood following the close-arterial infusion of [3H]-(-)-noradrenaline indicating that the drug inhibits uptake of the amine. 4. Both labetalol (3.8 X 10(-5) M) and piperoxan (7.4 X 10(-6) M) produced parallel shifts to the right of the dose-response curves to noradrenaline and oxymetazoline in isolated strips of cat splenic capsule. In this preparation both drugs acted as competitive postsynaptic alpha-adrenoceptor blocking agents. 5. Labetalol (3.3 X 10(-5) M) increased the transmitter overflow following stimulation of the splenic nerves with 200 impulses at 10 Hz. The overflow could be further increased by subsequent addition of piperoxan (7.2 X 10(-6 M). Piperoxan (5.7 X 10(-6) M) alone produced a marked increase in transmitter overflow which could be further increased by subsequent addition of desmethylimipramine (DMI; 3.2 X 10(-5) M). Cocaine (1.5 X 10(-5) M) or DMI (5.4 X 10(-5 M) produced a small increase in transmitter overflow which was not further increased by addition of labetalol (2.8 X 10(-5) M). 6. Labetalol produced a biphasic effect on the responses of the isolated blood perfused spleen of the cat to nerve stimulation. With low doses (up to 10(-4) M) vascular responses were potentiated and with high doses (greater than 10(-4) M) inhibited. The potentiation was related to uptake blockade and the inhibition to decreased transmitter overflow and postsynaptic alpha-adrenoceptor blockade. 7. Labetalol appears to act as a postsynaptic alpha-adrenoceptor antagonist in the isolated blood perfused spleen of the cat with little effect on presynaptic alpha-adrenoceptors. The moderate elevation of transmitter overflow by the drug is related to the inhibitory effect of the drug on neuronal uptake rather than on presynaptic alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 15698      PMCID: PMC1667764          DOI: 10.1111/j.1476-5381.1977.tb07733.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Proceedings: The effects of AH 5158 on the overflow of transmitter and the uptake of (3H)-(--)-noradrenaline in the cat spleen.

Authors:  A G Blakeley; R J Summers
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

2.  Pharmacological experiments on the release of the sympathetic transmitter.

Authors:  A G BLAKELEY; G L BROWN; C B FERRY
Journal:  J Physiol       Date:  1963-07       Impact factor: 5.182

3.  The output of sympathetic transmitter from the spleen of the cat.

Authors:  G L BROWN; J S GILLESPIE
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

4.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

5.  Comparison between the effects produced by chronic denervation and by cocaine on the sensitivity to, and on the disposition of, noradrenaline in isolated spleen strips.

Authors:  S Guimarães; F Brandão
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors.

Authors:  L Cubeddu; E M Barnes; S Z Langer; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1974-09       Impact factor: 4.030

7.  Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Alpha-sympathomimetic inhibition of Neurogenic vasoconstriction.

Authors:  K Starke; H Montel; W Gayk; R Merker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

8.  Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.

Authors:  I Kennedy; G P Levy
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

9.  Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine.

Authors:  S M Kirpekar; M Puig
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

10.  Role of the -adrenoceptor in regulating noradrenaline overflow by nerve stimulation.

Authors:  M A Enero; S Z Langer; R P Rothlin; F J Stefano
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

View more
  20 in total

Review 1.  Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.

Authors:  W H Frishman
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

2.  Circulatory and alpha-adrenoceptor blocking effects of phentolamine.

Authors:  D A Richards; E P Woodings; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

3.  The characteristics of [3H]-clonidine binding to an alpha-adrenoceptor in membranes from guinea-pig kidney.

Authors:  B Jarrott; W J Louis; R J Summers
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

4.  The effects of piperoxan on uptake of noradrenaline and overflow of transmitter in the isolated blood perfused spleen of the cat.

Authors:  A G Blakeley; R J Summers
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

Review 5.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

6.  Circulatory effects of noradrenaline and adrenaline before and after labetalol.

Authors:  D A Richards; B N Prichard; R Hernández
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

7.  The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.

Authors:  R T Brittain; G M Drew; G P Levy
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

8.  Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.

Authors:  G Keusch; P Weidmann; W H Ziegler; R de Châtel; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-01-02

Review 9.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

10.  Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.

Authors:  B J Milne; A G Logan
Journal:  Can Med Assoc J       Date:  1980-11-22       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.